Identifying type Vicenza von Willebrand disease

Alessandra Casonato , Elena Pontara , Francesca Sartorello , Maria Grazia Cattini , Lisa Gallinaro , Antonella Bertomoro , Antonio Rosato , Roberto Padrini , Antonio Pagnan
{"title":"Identifying type Vicenza von Willebrand disease","authors":"Alessandra Casonato ,&nbsp;Elena Pontara ,&nbsp;Francesca Sartorello ,&nbsp;Maria Grazia Cattini ,&nbsp;Lisa Gallinaro ,&nbsp;Antonella Bertomoro ,&nbsp;Antonio Rosato ,&nbsp;Roberto Padrini ,&nbsp;Antonio Pagnan","doi":"10.1016/j.lab.2005.10.002","DOIUrl":null,"url":null,"abstract":"<div><p>Increased clearance of von Willebrand factor (VWF) is one of the main features of type Vicenza von Willebrand disease (VWD), a variant with plasma and platelet VWF level discrepancies and unusually large VWF multimers. Diagnosing type Vicenza VWD may not be easy, due to its heterogeneous phenotype. Here we describe the criteria we adopted to identify type Vicenza in a large group of VWD patients. Emphasizing the contribution of platelet VWF by comparison with plasma values, a first step involved selecting the candidate Vicenza patients on the basis of low or very low plasma VWF and a normal platelet VWF content. After excluding type 2A and 2B VWD patients, who may have normal platelet VWF, 18 candidates were found to meet our selection criteria. Genetic analysis revealed that 15 patients (from 5 unrelated families) were type Vicenza VWD and that all carried both G2220A and G3614A type Vicenza mutations barring one, who only had the G3614A mutation. All patients had a reduced VWF survival, and all but the patient with the G3614A mutation alone had ultralarge VWF multimers. Thus, low-plasma VWF associated with a normal platelet VWF content may be a first useful indicator for identifying type Vicenza VWD patients.</p></div>","PeriodicalId":16273,"journal":{"name":"Journal of Laboratory and Clinical Medicine","volume":"147 2","pages":"Pages 96-102"},"PeriodicalIF":0.0000,"publicationDate":"2006-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.lab.2005.10.002","citationCount":"25","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Laboratory and Clinical Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022214305003483","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 25

Abstract

Increased clearance of von Willebrand factor (VWF) is one of the main features of type Vicenza von Willebrand disease (VWD), a variant with plasma and platelet VWF level discrepancies and unusually large VWF multimers. Diagnosing type Vicenza VWD may not be easy, due to its heterogeneous phenotype. Here we describe the criteria we adopted to identify type Vicenza in a large group of VWD patients. Emphasizing the contribution of platelet VWF by comparison with plasma values, a first step involved selecting the candidate Vicenza patients on the basis of low or very low plasma VWF and a normal platelet VWF content. After excluding type 2A and 2B VWD patients, who may have normal platelet VWF, 18 candidates were found to meet our selection criteria. Genetic analysis revealed that 15 patients (from 5 unrelated families) were type Vicenza VWD and that all carried both G2220A and G3614A type Vicenza mutations barring one, who only had the G3614A mutation. All patients had a reduced VWF survival, and all but the patient with the G3614A mutation alone had ultralarge VWF multimers. Thus, low-plasma VWF associated with a normal platelet VWF content may be a first useful indicator for identifying type Vicenza VWD patients.

维琴察血管性血友病的鉴别
血管性血友病(VWF)清除率增高是维琴察血管性血友病(VWD)的主要特征之一,是一种血浆和血小板VWF水平差异和VWF多肽异常大的变型。由于其异质表型,诊断维琴察型VWD可能不容易。在这里,我们描述了我们采用的标准,以确定维琴察型在一个大组的VWD患者。通过与血浆值的比较,强调血小板VWF的贡献,第一步是根据低或极低的血浆VWF和正常的血小板VWF含量选择候选维琴察患者。在排除可能具有正常血小板VWF的2A型和2B型VWD患者后,发现18名候选人符合我们的选择标准。遗传分析显示,15例患者(来自5个无亲缘关系家庭)均为维琴察型VWD,除1例患者仅携带G3614A突变外,其余患者均携带G2220A和G3614A型维琴察突变。所有患者的VWF生存率均降低,除单独携带G3614A突变的患者外,所有患者都有超大的VWF多聚体。因此,与血小板VWF含量正常相关的低血浆VWF可能是识别维琴察型VWD患者的第一个有用指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信